C4 Therapeutics
Price & Volume
Stats
See more52W Range | $1.08-$4.26 |
Market Cap | $195.7M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $30.1M |
Revenue Growth (YoY) | -26.9% |
Gross Profit (12 Mos) | -$81.6M |
Diluted EPS | -$1.67 |
News
See moreYahoo Finance • last month
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Yahoo Finance • last month
C4 Therapeutics files $400M mixed shelf offering
Yahoo Finance • last month
[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
Yahoo Finance • 2 months ago
C4 Therapeutics GAAP EPS of -$0.44 misses by $0.03, revenue of $11.23M beats by $4.95M
About
CEO | Mr. Andrew J. Hirsch M.B.A. |
CFO | Ms. Kendra Adams |
Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 110 |
